Gastric cancer screening in Chile. Results of the National Health Survey 2016-2017

Gastric cancer (GC) is the leading cause of oncologic death in Chile. Since 2006, the health authority has recommended upper gastrointestinal endoscopy (UGE) for symptomatic individuals ≥40 years old. In 2010, the UGE coverage in this group was estimated at 14%. To evaluate UGE coverage for GC scree...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista de gastroenterología del Perú Jg. 45; H. 1; S. 24
Hauptverfasser: Corsi Sotelo, Oscar, Fuentes-López, Eduardo, Latorre Selvat, Gonzalo, Espinoza Sepúlveda, Manuel A, Margozzini Maira, Paula, Monrroy Bravo, Hugo, Espino Espino, Alberto, Riquelme Pérez, Arnoldo
Format: Journal Article
Sprache:Spanisch
Veröffentlicht: Peru 01.01.2025
Schlagworte:
Adult
Aged
Chile - epidemiology
Early Detection of Cancer - statistics & numerical data
Endoscopy, Gastrointestinal - statistics & numerical data
Female
Health Surveys
Humans
Male
Middle Aged
Prevalence
Stomach Neoplasms - diagnosis
Stomach Neoplasms - epidemiology
Young Adult
Chile
ISSN:1609-722X, 1609-722X
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Gastric cancer (GC) is the leading cause of oncologic death in Chile. Since 2006, the health authority has recommended upper gastrointestinal endoscopy (UGE) for symptomatic individuals ≥40 years old. In 2010, the UGE coverage in this group was estimated at 14%. To evaluate UGE coverage for GC screening in Chile using data from the National Health Survey (NHS) 2016-17. The NHS 2016-17 surveyed 6,233 adults about the presence of persistent epigastric pain, possible upper gastrointestinal bleeding, and UGE. UGE prevalences among different groups were compared, and multivariate models adjusted for sex, age, income, education, area of residence, and belonging to an indigenous group were constructed. Both persistent epigastric pain and possible upper gastrointestinal bleeding were reported by 4.7%, being higher in the ≥ 40-year-old group and lower educational level. The prevalence of UGE performed at least once in life reached 20.8%, being higher in women, ≥40 years old, privately insured individuals, and the non-indigenous Hispanic population. The coverage of UGE in the last year among symptomatic individuals ≥40 years old increased to 19.8%, with no significant differences in the multivariate analysis. The coverage of UGE in the last year in symptomatic individuals ≥40 years old for GC screening in Chile is 19.8%. Lowest socioeconomic status and indigenous peoples are disadvantaged groups.
Bibliographie:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1609-722X
1609-722X